Tevogen Bio Holdings Inc. has announced its new artificial intelligence initiative, Tevogen.AIâ„¢, aimed at enhancing its ExacTcellâ„¢ technology for improved target identification and preclinical ...
Ultimately, Dr. Minn notes, success in immuno-oncology will be measured in multiple ways: Scientifically, by the depth of ...
Researchers have designed a new method for developing immunotherapy drugs using engineered peptides to elicit a natural immune response inside the body. In a new study published today in Nature ...
REDWOOD CITY, Calif. & SHENZHEN, China--(BUSINESS WIRE)--LTZ Therapeutics, an immunotherapy-focused biotech company, today announced the completion of the company’s Series A financing of over $20 ...
Members include Nobel laureate James P. Allison, Padmanee Sharma, Taha Merghoub, and Kingston Mills, who are all globally renowned experts in ...
Glioblastoma remains one of the most lethal primary brain tumors, with limited durable benefit from current standard-of-care approaches. In parallel, ...
Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research reveals a hidden trick: cancer cells can package the immune-blocking protein ...
Until recently, allergy treatment was largely based on average treatment schemes. A patient with pollen allergy would receive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results